drugset / Trial / NCT03593538

Effects of Metformin During Nicotine Withdrawal

NCT03593538 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the effects of a medication called metformin (Glucophage®) on smoking behavior. This medication is FDA-approved for treatment of type-2 diabetes. It is being used for research purposes in this study. Participants will be randomized to one of 3 treatment groups: low dose of metformin, high dose of metformin, or placebo.

Timeline

Start
2016-04-01
Primary completion
2020-03-13
Completion
2020-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —
Subject Metformin Small molecule 1500 mg —